• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    10.74 Down 1.48(12.11%) Feb 8, 4:00PM EST
    Prev Close:12.22
    Open:11.85
    Bid:N/A
    Ask:17.85 x 100
    1y Target Est:33.25
    Beta:0.887301
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:10.60 - 11.98
    52wk Range:10.60 - 41.97
    Volume:2,234,373
    Avg Vol (3m):1,947,440
    Market Cap:486.21M
    P/E (ttm):N/A
    EPS (ttm):-4.83
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SRPT

    Comparison

    Symbol% ChgMkt Cap
    SRPTDown 12.11%486.21M
    GSKDown 3.16%95.52B
    ALNYDown 7.59%5.14B
    ISIS 0.00%6.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):20,489.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.88
    Quarterly EPS Est (Dec-15) :-1.18
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):11.00

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback